Boston Scientific (NYSE:BSX) released new clinical trial results for its FARAPULSE PFA Platform and WATCHMAN LAAC at Heart ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Boston Scientific (NYSE:BSX) today shared new clinical findings supporting its wide-ranging electrophysiology (EP) portfolio.
Detailed price information for Abbott Laboratories (ABT-N) from The Globe and Mail including charting and trades.
Medical device company Boston Scientific (NYSE:BSX) announced better-than-expected revenue in Q1 CY2026, with sales up 11.6% year on year to $5.20 billion. On the other hand, next quarter’s revenue ...
With CMS’ recent approval of electrophysiology ablation procedures for the ASC setting, leaders are faced with a range of new ...
Boston Scientific, Abbott and Medtronic shared new cardiac device data at the annual Heart Rhythm Society meeting, where ...
Over the last weekend, Chicago played host to the 2026 edition of the Heart Rhythm Society's annual conference (HRS 2026).
Hosted on MSN
BSX Q1 deep dive: Market outperformance despite lowered guidance and product-specific headwinds
・ WATCHMAN volume shifts: The company experienced a decline in standalone WATCHMAN procedures, offset by growing demand for combined (concomitant) procedures. Management cited hospital workflow ...
Non-AI Stocks Weighing Down Stephen Mandel’s 2026 Returns and Boston Scientific Corporation (NYSE:BSX) ranks 1st on this list ...
Kileleshwa MCA Robert Alai demands thorough investigation into Consolata "Connie" Githinji’s death at an AirBnB, urging ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results